Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 9

    Cabinet approves big package for promotion of Domestic Manufacturing of Medical Devices, details

    Cabinet approves big package for promotion of Domestic Manufacturing of Medical Devices, details

    Medical Dialogues Bureau23 March 2020 12:58 PM IST
    Delhi: With an aim to provide boost to the domestic manufacturing of medical devices in the country, the Union Cabinet recently has given a...
    Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

    Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

    Medical Dialogues Bureau23 March 2020 9:30 AM IST
    It is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13...
    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Medical Dialogues Bureau22 March 2020 2:00 PM IST
    Delhi: Recently Central Drugs Standard Control Organization, Directorate General of Health Services has issued a notice regarding the measures to...
    GE Healthcare to produce ventilators round-the-clock to meet coronavirus-led demand

    GE Healthcare to produce ventilators round-the-clock to meet coronavirus-led demand

    Medical Dialogues Bureau22 March 2020 1:47 PM IST
    GE did not disclose how many additional ventilators it expected to produce or the number of people it plans to hire.
    Novartis receives Japanese approval for Zolgensma for spinal muscular atrophy

    Novartis receives Japanese approval for Zolgensma for spinal muscular atrophy

    Medical Dialogues Bureau22 March 2020 11:45 AM IST
    Zolgensma is a one-time gene therapy designed to address the genetic root cause of the disease by replacing the function of the missing or nonworking...
    Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine

    Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine

    Medical Dialogues Bureau22 March 2020 9:00 AM IST
    New York: Pfizer Inc. has announced top-line results from one of its Phase 3 studies, which evaluated the safety and immunogenicity of its 20-valent...
    Coronavirus: Govt puts immediate ban on Export of  Masks, Ventilators and textile raw material for masks and coveralls

    Coronavirus: Govt puts immediate ban on Export of Masks, Ventilators and textile raw material for masks and coveralls

    Medical Dialogues Bureau21 March 2020 2:22 PM IST
    Delhi: To prevent any kind of shortage in the country in the scenario of coronavirus, the export of Ventilators, Surgical/Disposable Masks (2/3...
    Merck Announces positive results for Gefapixant  Phase 3 Trial to treat Chronic Cough

    Merck Announces positive results for Gefapixant Phase 3 Trial to treat Chronic Cough

    Medical Dialogues Bureau21 March 2020 10:15 AM IST
    Kenilworth: Merck, known as MSD outside the United States and Canada, has announced top-line efficacy results from two ongoing pivotal Phase 3...
    AstraZenecas Phase III CASPIAN trial final analysis shows Imfinzi confirmed survival benefit for small cell lung cancer patients

    AstraZeneca's Phase III CASPIAN trial final analysis shows Imfinzi confirmed survival benefit for small cell lung cancer patients

    Medical Dialogues Bureau21 March 2020 9:00 AM IST
    Imfinzi confirmed a sustained overall survival benefit in the final analysis of the Phase III CASPIAN trial in 1st-line extensive-stage small cell...
    Dr Reddys Labs launches Naloxone Hydrochloride Injection in US Market

    Dr Reddy's Labs launches Naloxone Hydrochloride Injection in US Market

    Medical Dialogues Bureau21 March 2020 9:00 AM IST
    Hyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL)...
    Prices of Alcohols used in manufacturing hand sanitizers capped under the Essential Commodities Act

    Prices of Alcohols used in manufacturing hand sanitizers capped under the Essential Commodities Act

    Medical Dialogues Bureau20 March 2020 2:23 PM IST
    This will help the manufacturers of hand sanitizers to keep prices of their and product at reasonable and within the reach of the common people.
    Dr Reddys Labs launches Pyrimethamine Tablets in US

    Dr Reddy's Labs launches Pyrimethamine Tablets in US

    Medical Dialogues Bureau20 March 2020 12:14 PM IST
    Dr Reddy’s Pyrimethamine Tablets USP, is available in 25 mg dose in bottle count sizes of 30 and 100.
    PrevNext

    Popular Stories

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok